Open Access Highly Accessed Research article

Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy

Shadi Mamaghani, Satish Patel and David W Hedley*

BMC Cancer 2009, 9:132 doi:10.1186/1471-2407-9-132

No comments have yet been made on this article.

Post a comment